Bill > HF2906

This bill establishes a legal framework for the therapeutic use of psilocybin, a psychoactive compound found in certain mushrooms, for individuals aged 21 and older who have a diagnosed qualifying medical condition, such as PTSD, depression, or substance use disorders. The program requires individuals to be enrolled and to work with a registered facilitator, who is a licensed professional trained to guide patients through preparation sessions before, administration sessions during, and integration sessions after psilocybin use. The bill outlines strict regulations for registered suppliers who cultivate psilocybin, ensuring quality and safety through testing facilities, and for treatment facilities where administration sessions can occur. It also establishes protections for registered patients, facilitators, and healthcare practitioners involved in the program, preventing discrimination in employment, housing, and education, and provides for criminal penalties for diversion or misuse of psilocybin. Furthermore, the bill creates a Psychedelic Medicine Advisory Committee to guide the commissioner of health in developing rules and overseeing the program, and appropriates funds for its implementation and for research into psilocybin's therapeutic potential. Importantly, this bill also amends existing law to remove psilocybin and psilocin from the state's Schedule I controlled substances list, reclassifying them under Schedule IV, which is a less restrictive category.

Business and Industry, Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF2906&ssn=0&y=2025